Hofseth International already owns around 15% of Hofseth Biocare, according to the Holdings service. Roger Hofseth owns 18% of the company.

In July, Roger Hofseth stepped down from his position as CEO of HBC, handing control of the company over to Jon Olav Odegard, who had been company’s chief financial officer.